BECOTIDE

This brand name is authorized in France, Ireland, Italy, South Africa, Spain.

Active ingredients

The drug BECOTIDE contains one active pharmaceutical ingredient (API):

1	Beclometasone UNII 5B307S63B2 - BECLOMETHASONE DIPROPIONATE
	Beclometasone is a pro-drug with weak glucocorticoid receptor binding affinity. It is extensively hydrolysed via esterase enzymes to the active metabolite beclometasone-17-monopropionate (B-17-MP), which has potent topical anti-inflammatory activity.
	Read more about Beclometasone

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
BECOTIDE EVOHALER Pressurised inhalation, solution	MPI, EU: SmPC	Health Products Regulatory Authority (IE)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
R03BA01	Beclometasone	R Respiratory system → R03 Drugs for obstructive airway diseases → R03B Other drugs for obstructive airway diseases, inhalants → R03BA Glucocorticoids
Discover more medicines within R03BA01

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
ES	Centro de información online de medicamentos de la AEMPS	52810
FR	Base de données publique des médicaments	61749562, 62013175
IE	Health Products Regulatory Authority	58250, 58281, 58297, 58303
IT	Agenzia del Farmaco	023378072
ZA	Health Products Regulatory Authority	E/21.5.1/122, N/21.5.1/0056, N/21.5.1/0057, W/21.5.1/131